Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.13
ASNB's Cash to Debt is ranked lower than
66% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. ASNB: 0.13 )
ASNB' s 10-Year Cash to Debt Range
Min: 0.04   Max: No Debt
Current: 0.13

Equity to Asset 0.06
ASNB's Equity to Asset is ranked lower than
68% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. ASNB: 0.06 )
ASNB' s 10-Year Equity to Asset Range
Min: -0.32   Max: 0.97
Current: 0.06

-0.32
0.97
F-Score: 5
Z-Score: -17.94
M-Score: -3.75
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Revenue Growth (%) 14.50
ASNB's Revenue Growth (%) is ranked lower than
74% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. ASNB: 14.50 )
ASNB' s 10-Year Revenue Growth (%) Range
Min: -57.3   Max: 106.6
Current: 14.5

-57.3
106.6
EBITDA Growth (%) -100.00
ASNB's EBITDA Growth (%) is ranked lower than
88% of the 231 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.10 vs. ASNB: -100.00 )
ASNB' s 10-Year EBITDA Growth (%) Range
Min: -100   Max: 49.4
Current: -100

-100
49.4
EPS Growth (%) -48.90
ASNB's EPS Growth (%) is ranked lower than
86% of the 237 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. ASNB: -48.90 )
ASNB' s 10-Year EPS Growth (%) Range
Min: -48.9   Max: 33.2
Current: -48.9

-48.9
33.2
» ASNB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with ASNB



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 6.00
ASNB's P/B is ranked lower than
64% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. ASNB: 6.00 )
ASNB' s 10-Year P/B Range
Min: 0.15   Max: 8
Current: 6

0.15
8
P/S 0.50
ASNB's P/S is ranked lower than
64% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. ASNB: 0.50 )
ASNB' s 10-Year P/S Range
Min: 0.11   Max: 50
Current: 0.5

0.11
50
EV-to-EBIT -14.89
ASNB's EV-to-EBIT is ranked lower than
64% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.19 vs. ASNB: -14.89 )
ASNB' s 10-Year EV-to-EBIT Range
Min: 6.3   Max: 976.1
Current: -14.89

6.3
976.1
Current Ratio 1.03
ASNB's Current Ratio is ranked lower than
68% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.79 vs. ASNB: 1.03 )
ASNB' s 10-Year Current Ratio Range
Min: 0.67   Max: 32
Current: 1.03

0.67
32
Quick Ratio 0.74
ASNB's Quick Ratio is ranked lower than
68% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. ASNB: 0.74 )
ASNB' s 10-Year Quick Ratio Range
Min: 0.55   Max: 32
Current: 0.74

0.55
32

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 6.00
ASNB's Price/Tangible Book is ranked lower than
64% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.06 vs. ASNB: 6.00 )
ASNB' s 10-Year Price/Tangible Book Range
Min: 0.26   Max: 306.3
Current: 6

0.26
306.3
Price/Median PS Value 0.29
ASNB's Price/Median PS Value is ranked lower than
64% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.11 vs. ASNB: 0.29 )
ASNB' s 10-Year Price/Median PS Value Range
Min: 0.09   Max: 17
Current: 0.29

0.09
17
Earnings Yield (Greenblatt) 6.90
ASNB's Earnings Yield (Greenblatt) is ranked lower than
81% of the 252 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.20 vs. ASNB: 6.90 )
ASNB' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 15.9
Current: 6.9

0.1
15.9
Forward Rate of Return (Yacktman) -213.22
ASNB's Forward Rate of Return (Yacktman) is ranked lower than
78% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.95 vs. ASNB: -213.22 )
ASNB' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -681.5   Max: 13.8
Current: -213.22

-681.5
13.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
AdvanSource Biomaterials Corporation, formerly known as CardioTech International, Inc., was founded in 1993 as a subsidiary of PolyMedica Corporation. It develops polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating anatomical sites and disease states. Its edge technology, notably products such as ChronoFlex, ChronoSilTM, HydroMed, and HydroThane, has been developed to overcome a design and functional challenges. It also manufactures and sells its proprietary HydroThane polymers to medical device manufacturers that are evaluating HydroThane for use in their products. HydroThane is a thermoplastic, water-absorbing, polyurethane elastomer possessing properties which is suited for the complex requirements of a variety of catheters. In addition to its physical properties, HydroThane exhibits an inherent degree of bacterial resistance, clot resistance and biocompatibility. When hydrated, HydroThane has elastic properties similar to living tissue. The Company also manufactures specialty hydrophilic polyurethanes that are primarily sold to customers as part of exclusive arrangements.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide